Screener
Eligibility screening
Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
103 US sites in AL, AR, AZ, CA +35
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.